Silence Therapeutics PLC (OTCPK:SLNCF)
$ 6.115 0.615 (11.18%) Market Cap: 858.51 Mil Enterprise Value: 662.84 Mil PE Ratio: 0 PB Ratio: 6.00 GF Score: 44/100

Silence Therapeutics PLC at Needham Healthcare Conference (Virtual) Transcript

Apr 14, 2021 / 12:45PM GMT
Release Date Price: $7.34 (-4.30%)
Vincent Kover

Good morning, everyone. Thank you for joining Day 3 of Needham's 20th Annual Healthcare Conference. My name is Vincent Kover, I sit on Needham's institutional equities team. I have the pleasure this morning of introducing Silence Therapeutics. They are a $673 million market cap company, who trade under the symbol SLN. We have Mark Rothera with us, who is the President and CEO. We'll also be joined later on after the presentation by Craig Tooman and Giles Campion for our Q&A.

Once Mark is finished with the presentation, we'll move into about a 10-minute Q&A. Please feel free to use the text box underneath your screen to enter any questions over the course of the presentation.

Mark, thank you so much for joining us today. I'll turn the floor over to you.

Mark Andrew Rothera
Silence Therapeutics plc - President, CEO & Executive Director

Vincent, thank you very much for the invitation. Good morning to all those participating in the U.S. Good afternoon to those who are in the U.K., as I am today.

So Silence is a well

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot